Literature DB >> 26748832

Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders.

Yuko Saito1, Ayako Shioya1,2, Terunori Sano1, Hiroyuki Sumikura3,4, Miho Murata5, Shigeo Murayama3,4.   

Abstract

BACKGROUND: The "dual-hit" and propagation hypotheses of α-synuclein suggests that the olfactory cells of the olfactory epithelium are among the earliest sites of involvement in Parkinson's disease (PD). We investigated the olfactory epithelium in consecutive cases that had been registered with a brain bank.
OBJECTIVES: This study was undertaken to check the presence or absence of Lewy body pathology in olfactory cells.
METHODS: Thirty-six male and 11 female patients were examined, including eight with PD, two with dementia with Lewy bodies, 11 with incidental Lewy body disease, and 26 with no Lewy-related alpha-synucleinopathy. The olfactory epithelium was sampled by craniotomy followed by resection of the cribriform plate, which was fixed in formalin and decalcified with ethylenediaminetetra-acetate. Coronal paraffin-embedded sections of the plate were stained with hematoxylin and eosin or immunohistochemically stained with antibodies against phosphorylated α-synuclein to detect Lewy body pathology and neuronal markers of protein gene product 9.5, phosphorylated neurofilament, and tyrosine hydroxylase.
RESULTS: Lewy body pathology was detected in the olfactory cells of the olfactory epithelium in a single patient with incidental Lewy body disease and in six patients with PD, but it was not detected in patients who had dementia with Lewy bodies.
CONCLUSIONS: We detected Lewy body pathology in the olfactory epithelium in six of the eight patients with Parkinson's disease and in one patient with incidental Lewy body pathology.
© 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Braak stage; alpha-synuclein; amygdala; hyposmia; olfactory bulb

Mesh:

Substances:

Year:  2016        PMID: 26748832     DOI: 10.1002/mds.26463

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

1.  Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson's Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque.

Authors:  James B Koprich; Tom H Johnston; Gabriela Reyes; Vanessa Omana; Jonathan M Brotchie
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

2.  Differential Effects of Parkinson's Disease on Interneuron Subtypes within the Human Anterior Olfactory Nucleus.

Authors:  Isabel Ubeda-Bañon; Alicia Flores-Cuadrado; Daniel Saiz-Sanchez; Alino Martinez-Marcos
Journal:  Front Neuroanat       Date:  2017-12-05       Impact factor: 3.856

Review 3.  Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.

Authors:  Rimona S Weil; Tammaryn L Lashley; Jose Bras; Anette E Schrag; Jonathan M Schott
Journal:  F1000Res       Date:  2017-08-30

4.  Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys.

Authors:  Christian Pifl; Harald Reither; Natalia Lopez-Gonzalez Del Rey; Carmen Cavada; Jose A Obeso; Javier Blesa
Journal:  Front Neuroanat       Date:  2017-05-29       Impact factor: 3.856

5.  Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

Authors:  Michael G Schlossmacher; Julianna J Tomlinson; Goncalo Santos; Bojan Shutinoski; Earl G Brown; Douglas Manuel; Tiago Mestre
Journal:  Eur J Neurosci       Date:  2016-12-27       Impact factor: 3.386

6.  Microarray Analysis of the Molecular Mechanism Involved in Parkinson's Disease.

Authors:  Cheng Tan; Xiaoyang Liu; Jiajun Chen
Journal:  Parkinsons Dis       Date:  2018-03-01

7.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

Review 8.  What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?

Authors:  Małgorzata Kujawska; Jadwiga Jodynis-Liebert
Journal:  Int J Mol Sci       Date:  2018-11-12       Impact factor: 5.923

9.  A ventral glomerular deficit in Parkinson's disease revealed by whole olfactory bulb reconstruction.

Authors:  Bolek Zapiec; Birger V Dieriks; Sheryl Tan; Richard L M Faull; Peter Mombaerts; Maurice A Curtis
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

10.  Recent Advances in Biomarkers for Parkinson's Disease.

Authors:  Runcheng He; Xinxiang Yan; Jifeng Guo; Qian Xu; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-10-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.